Cellular Dynamics International (CDI) has changed its structure, dividing into two separate business units: Therapeutics, to develop stem cell-based drugs, and Life Science, focusing on research products.

“By creating a market-oriented organization, operations in Madison can grow much more rapidly,” Kazuyoshi Hirao, chairman and CEO, said in an email exchange.

Founded by UW-Madison stem cell pioneer James Thomson in 2004, CDI was acquired by Japanese conglomerate Fujifilm Holdings Corp. for $307 million in April 2015. Read the full story here.